Systemic drug-related intertriginous and flexural exanthema-like eruption after Oxford-AstraZeneca COVID-19 vaccine.


Journal

Clinical and molecular allergy : CMA
ISSN: 1476-7961
Titre abrégé: Clin Mol Allergy
Pays: England
ID NLM: 101152195

Informations de publication

Date de publication:
12 Dec 2022
Historique:
received: 01 06 2022
accepted: 05 10 2022
entrez: 12 12 2022
pubmed: 13 12 2022
medline: 13 12 2022
Statut: epublish

Résumé

Systemic drug-related intertriginous and flexural exanthema (SDRIFE) is an adverse drug reaction which manifests as a symmetrical erythematous rash involving the skin folds after systemic drug exposure. A vast array of possible side effects associated with administration of different anti-SARS-CoV-2 vaccines have been reported in literature since the beginning of the COVID-19 pandemic, but only few times SDRIFE-like eruptions have been described in this context. We discuss here a case of SDRIFE-like eruption following the second dose of Oxford-Astrazeneca Vaxzevria vaccine.

Identifiants

pubmed: 36503530
doi: 10.1186/s12948-022-00179-8
pii: 10.1186/s12948-022-00179-8
pmc: PMC9742018
doi:

Types de publication

Letter

Langues

eng

Pagination

13

Informations de copyright

© 2022. The Author(s).

Références

Contact Dermatitis. 2022 Jul;87(1):91-93
pubmed: 35243643
Int J Dermatol. 2017 May;56(5):571-572
pubmed: 28217835
Clin Pharmacol Ther. 1981 Aug;30(2):239-45
pubmed: 7249508
Dermatol Online J. 2009 Aug 15;15(8):3
pubmed: 19891911
J Eur Acad Dermatol Venereol. 2022 Feb;36(2):172-180
pubmed: 34661927
J Eur Acad Dermatol Venereol. 2021 Oct;35(10):e634-e635
pubmed: 34138472
Dermatol Ther. 2022 Jul;35(7):e15546
pubmed: 35485220
J Dermatol Case Rep. 2015 Mar 31;9(1):12-4
pubmed: 25932057
Dermatol Clin. 2021 Oct;39(4):653-673
pubmed: 34556254
J Clin Med. 2021 Nov 16;10(22):
pubmed: 34830627
JAAD Case Rep. 2015 May 25;1(3):147-9
pubmed: 27051713
Am J Clin Dermatol. 2011 Jun 1;12(3):171-80
pubmed: 21469762
JAAD Case Rep. 2021 Dec;18:57-60
pubmed: 34722840
Contact Dermatitis. 2018 Dec;79(6):378-380
pubmed: 30062790
J Eur Acad Dermatol Venereol. 2022 Aug;36(8):e597-e599
pubmed: 35344627
Clin Exp Dermatol. 2022 Jan;47(1):175-176
pubmed: 34399001
Curr Opin Allergy Clin Immunol. 2011 Aug;11(4):313-8
pubmed: 21659857

Auteurs

Danilo Di Bona (D)

Department of Emergency and Organ Transplantation, School of Allergology and Clinical Immunology, University of Bari Aldo Moro, Policlinico di Bari, Bari, Italy.
Unit of Allergology, Azienda Ospedaliero Universitaria Consorziale Policlinico, Bari Piazza Giulio Cesare, 11., 70124, Bari, Italy.

Andrea Miniello (A)

Department of Emergency and Organ Transplantation, School of Allergology and Clinical Immunology, University of Bari Aldo Moro, Policlinico di Bari, Bari, Italy.
Unit of Allergology, Azienda Ospedaliero Universitaria Consorziale Policlinico, Bari Piazza Giulio Cesare, 11., 70124, Bari, Italy.

Eustachio Nettis (E)

Unit of Allergology, Azienda Ospedaliero Universitaria Consorziale Policlinico, Bari Piazza Giulio Cesare, 11., 70124, Bari, Italy. ambulatorio.allergologia@uniba.it.

Classifications MeSH